Tempus, a leader in artificial intelligence and precision medicine, announced the integration of its signature Tempus One technology into its Lens data analytics platform....
Tempus, a leader in artificial intelligence and precision medicine, announced the addition of a novel MRD assay, xM, to its comprehensive testing solutions. The...
Tempus, a leader in artificial intelligence and precision medicine, announced xF Monitor – a new circulating tumor DNA (ctDNA) assay for research use only,...
Study aims to create the most robust, multi-omic dataset for patients with NSCLC
Tempus, a leader in artificial intelligence and precision medicine, announces its GEMINI...